Cancer News and Research

Latest Cancer News and Research

Impact of Texas family planning affiliation regulation

As a federal appeals court considers the legality of Texas' family planning "affiliation regulation," a new report provides a preliminary assessment of the impact of the Texas rule on preventive care access by low-income women.

3 May 2012

Reuters examines cancer in Africa

Reuters examines cancer in Africa, writing, "Most of Africa's around 2,000 languages have no word for cancer. The common perception in both developing and developed countries is that it's a disease of the wealthy world, where high-fat, processed-food diets, alcohol, smoking and sedentary lifestyles fuel tumor growth."

3 May 2012

Combination of two mTOR inhibitors stops growth of hepatocellular carcinoma

The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute.

3 May 2012

HSPH introduces Obesity Prevention Source website

What is causing the obesity epidemic-and how can we stop and reverse this worldwide weight problem? A new website offers authoritative answers to these pressing questions and sheds light on one of the most challenging public health threats of our time.

3 May 2012

New clues about why immune system fails to kill tumors in mice

A pioneering approach to imaging breast cancer in mice has revealed new clues about why the human immune system often fails to attack tumors and keep cancer in check. This observation, by scientists at the University of California, San Francisco (UCSF), may help to reveal new approaches to cancer immunotherapy.

3 May 2012

Ben & Catherine Ivy Foundation to fund $45,000 pilot internship program at TGen

The Arizona-based Ben & Catherine Ivy Foundation will fund a $45,000 pilot internship program this summer and fall at the Translational Genomics Research Foundation (TGen).

3 May 2012

Federal appeals judge reverses Monday ruling, allows Texas to exclude Planned Parenthood from Women's Health Program

A second federal judge in Texas issued an injunction allowing Texas to exclude Planned Parenthood from Texas' Women's Health Program -- for now -- a day after another judge in Texas had ruled the state couldn't bar the group from the health program. The judge who ruled Tuesday has ordered Planned Parenthood to respond by Tuesday afternoon.

3 May 2012

HiLo trial sets new gold standard for thyroid cancer treatment

The results of a large Cancer Research UK trial have set a new gold standard for treating thyroid cancer, reducing radiation doses to just one third of the current level, according to research in The New England Journal of Medicine.

3 May 2012

First Edition: May 2, 2012

Today's headlines include a report that House Republican lawmakers want to cut bonuses to states for enrolling low-income kids in Medicaid and the Children's Health Insurance Program.

3 May 2012

Women with benign breast biopsies do not need follow-up at six months

Contrary to current guidelines, women with benign breast biopsies do not need follow-up at six months; they may not need close surveillance at all, a new study shows.

3 May 2012

Scientists determine structure of green pigment seen in nitrite-cured bacon, other meats

As with many concerned consumers, a team of University of Oklahoma researchers wondered if the green color sometimes seen in bacon is, in fact, harmful to human health. Recently, these OU scientists took an important first step in answering this question by determining the structure of the green pigment responsible for this 'nitrite burn.'

3 May 2012

Math models can be useful tools for study of cancer progression

Using mathematical models, researchers in the Integrated Mathematical Oncology (IMO) program at Moffitt Cancer Center are focusing their research on the interaction between the tumor and its microenvironment and the "selective forces" in that microenvironment that play a role in the growth and evolution of cancer.

3 May 2012

MRA, Sports Authority partner in recognition of May's Skin Cancer Awareness Month

Sports Authority, the nation's premier full-line sporting goods retailer, announced today that it has teamed up with the Melanoma Research Alliance (MRA) in recognition of May's Skin Cancer Awareness Month for the second year in a row.

3 May 2012

EKOS launches two landmark clinical studies on pulmonary embolism

EKOS Corporation today announced the launch of two more landmark clinical studies named SEATTLE I & II, intended to further establish the safety and efficacy of its unique, ultrasound-accelerated thrombolysis in treating patients with life-threatening pulmonary embolism.

3 May 2012

Ligand first quarter total revenues increase to $5.6 million

Ligand Pharmaceuticals Incorporated today reported financial results for the first quarter ended March 31, 2012, and provided an operating forecast and program updates.

3 May 2012

Roundup: Mass. health cost control bill could save $8B to $34B; Md. weighs hospital rate freeze; Iowa Senate passes a fix for HIV insurance program

As Massachusetts' state legislators put the finishing touches on a major health care cost-control bill, there is still one big question: How much could it save? A recent report claims employers and employees could see between $8 billion and $34.5 billion in savings over nine years.

3 May 2012

Misleading information about breast brachytherapy

One of the leading experts on radiation therapy for breast cancer says a new study in JAMA -- about breast cancer treatment - has misleading information and may unnecessarily deter women from getting breast brachytherapy, a safe and effective treatment.

2 May 2012

German BfArM grants Moberg Derma approval to initiate Limtop phase II actinic keratosis trial

The German Federal Institute for Drugs and Medical Devices (BfArM) has granted Moberg Derma approval to initiate a clinical phase II trial for Limtop. The aim is to evaluate the efficacy and safety of three different dose regimens of Limtop in a study involving 96 patients with Actinic Keratosis (AK) on the head or face.

2 May 2012

Optimum blood vitamin D levels to reduce risk of major medical events

In testing older patients' blood vitamin D levels, there's uncertainty about where the dividing line falls between enough and not enough. The threshold amount has become controversial as several scientific societies set different targets.

2 May 2012

ImmuVen awarded $1.68M NIH Phase II SBIR grant to develop IMV0123

ImmuVen was awarded a Phase II Small Business Innovation Research (SBIR) grant totaling $1.68 million from the National Institute for Allergy and Infectious Disease (NIH) for continuing development of its therapeutic pipeline (IMV0123) against superantigens produced by methicillin-sensitive and methicillin-resistant Staphylococcal aureus.

2 May 2012